NYSE: WLKPWestlake Chemical Partners LP Stock
$23.05+0.08 (+0.35%)
Updated Apr 17, 2025
WLKP Price
$23.05
Fair Value Price
N/A
Market Cap
$812.25M
52 Week Low
$21.19
52 Week High
$25.04
P/E
13.02x
P/B
2.94x
P/S
0.72x
PEG
11.3x
Dividend Yield
6.14%
Revenue
$1.14B
Earnings
$62.39M
Gross Margin
36.9%
Operating Margin
7.83%
Profit Margin
5.5%
Debt to Equity
1.66
Operating Cash Flow
$485M
Beta
0.51
Next Earnings
Apr 29, 2025
Ex-Dividend
N/A
Next Dividend
N/A
WLKP Overview
Westlake Chemical Partners Limited Partnership operates ethylene production facilities and related assets in the U.S. Its production facilities primarily convert ethane into ethylene. The company also sells ethylene co-products (propylene, crude butadiene, pyrolysis gasoline, and hydrogen) directly to third parties on either a spot or contract basis. Westlake Chemical Partners GP LLC serves as the general partner of the company. The company was incorporated in 2014 and is headquartered in Houston, TX.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine WLKP's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
Zen Rating Component Grades
B
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important WLKP news, forecast changes, insider trades & much more!
WLKP News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how WLKP scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
WLKP ($23.05) is trading above its intrinsic value of $10.32, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
WLKP is good value based on its earnings relative to its share price (13.02x), compared to the US market average (27.98x)
P/E vs Market Valuation
WLKP is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more WLKP due diligence checks available for Premium users.
Valuation
WLKP price to earnings (PE)
For valuing profitable companies with steady earnings
Company
13.02x
Industry
9.73x
Market
27.98x
WLKP is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
WLKP is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
WLKP price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.94x
Industry
1.02x
WLKP is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
WLKP price to earnings growth (PEG)
For valuing profitable companies with growth potential
WLKP is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
WLKP's financial health
Profit margin
Revenue
$290.1M
Net Income
$15.0M
Profit Margin
5.2%
WLKP's Earnings (EBIT) of $88.93M... subscribe to Premium to read more.
Interest Coverage Financials
WLKP's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.3B
Liabilities
$458.6M
Debt to equity
1.66
WLKP's short-term assets ($240.93M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
WLKP's long-term liabilities ($403.27M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
WLKP's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
WLKP's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$132.5M
Investing
-$38.5M
Financing
-$95.9M
WLKP's operating cash flow ($485.00M)... subscribe to Premium to read more.
Debt Coverage Financials
WLKP vs Chemical Stocks
Westlake Chemical Partners Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.